Thankfully safety is looking pretty good according to the press release. However I look forward to reading expert analyses of the actual data to confirm.

> However, the data presented is not the final analysis as it is based on only the first 94 volunteers to develop Covid so the precise effectiveness of the vaccine may change when the full results are analysed.

Thanks! Misread the 94, but the n=43.5k is also misleading since they have not analyzed all of the results and duration of the study vs exposure risk is still tbd. If the 94 participants that got COVID also abided by all the other precautions, such as masks, etc, then it stands to reason that the actual infection rate in the population approximating pre-covid behaviors may also be higher.

To be clear: 94 out of 43500 people in the trial got covid, and if the vaccine is rated at > 90% effectiveness, that means at least 85 of those 94 people were in the placebo group, and less than 10 people were in the vaccinated group.